Author | Giavanna Russo-Alvarez, PharmD, BCACP

Articles

SGLT2 Inhibitors: Pros, Cons, Comparisons, and Considerations

July 22, 2014

There are 2 FDA-approved sodium-glucose contransporter-2 inhibitors available in the United States. Here, a concise review of advantages/disadvantages and considerations in patient selection.